Boai NKY Medical Holdings Ltd. (SHE:300109)
China · Delayed Price · Currency is CNY 18.79
+0.46 (2.51%)
Jan 22, 2026, 12:24 PM CST
Boai NKY Medical Holdings Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Operating Revenue | 1,428 | 1,588 | 1,562 | 1,449 | 1,196 | 965.24 | Upgrade |
Other Revenue | 18.81 | 18.81 | 20.93 | 36.66 | 23.94 | 13.29 | Upgrade |
| 1,447 | 1,606 | 1,583 | 1,486 | 1,220 | 978.53 | Upgrade | |
Revenue Growth (YoY) | -2.76% | 1.45% | 6.58% | 21.75% | 24.70% | 5.85% | Upgrade |
Cost of Revenue | 860.99 | 856.29 | 689.03 | 795.1 | 732.99 | 548.37 | Upgrade |
Gross Profit | 585.83 | 750.03 | 894.39 | 690.59 | 487.28 | 430.16 | Upgrade |
Selling, General & Admin | 191.16 | 206.41 | 235.76 | 188.03 | 253.44 | 194.16 | Upgrade |
Research & Development | 85.49 | 71.51 | 63.71 | 65.73 | 75.53 | 70.27 | Upgrade |
Other Operating Expenses | 11.42 | 12.69 | 13.97 | 9.6 | 11.45 | 9.77 | Upgrade |
Operating Expenses | 299.69 | 317.26 | 323.04 | 309.18 | 352.11 | 299.91 | Upgrade |
Operating Income | 286.14 | 432.78 | 571.35 | 381.42 | 135.17 | 130.25 | Upgrade |
Interest Expense | -7.97 | -7.04 | -2.07 | -2.62 | -37.73 | -51.56 | Upgrade |
Interest & Investment Income | 38.25 | 36.97 | 13.59 | 23.53 | 235.9 | 5.58 | Upgrade |
Currency Exchange Gain (Loss) | 5.04 | 5.04 | -1.4 | 23.11 | -0.8 | -2.06 | Upgrade |
Other Non Operating Income (Expenses) | -5.28 | -7.51 | -3.37 | -6.45 | -7.41 | 17.28 | Upgrade |
EBT Excluding Unusual Items | 316.19 | 460.24 | 578.11 | 418.99 | 325.13 | 99.49 | Upgrade |
Impairment of Goodwill | -44.85 | -44.85 | - | - | -60.51 | -39.95 | Upgrade |
Gain (Loss) on Sale of Investments | 10.64 | -13.22 | -1.07 | -37.83 | 14.15 | 2.55 | Upgrade |
Gain (Loss) on Sale of Assets | 6.04 | 0.09 | 0.04 | -0.87 | -0.46 | -0.83 | Upgrade |
Asset Writedown | -1.52 | -1.52 | -0.36 | -0.11 | -0.11 | -0.33 | Upgrade |
Other Unusual Items | 0.52 | 0.52 | 8.63 | 8.29 | 9.91 | 6.09 | Upgrade |
Pretax Income | 287.01 | 401.26 | 585.36 | 388.47 | 288.1 | 67.02 | Upgrade |
Income Tax Expense | 54.35 | 56.25 | 99.57 | 107.04 | 93.27 | 34.38 | Upgrade |
Earnings From Continuing Operations | 232.67 | 345.01 | 485.79 | 281.43 | 194.82 | 32.64 | Upgrade |
Minority Interest in Earnings | 6.86 | 4.67 | 7.24 | 10.03 | 12.22 | 11.93 | Upgrade |
Net Income | 239.53 | 349.68 | 493.03 | 291.46 | 207.05 | 44.57 | Upgrade |
Net Income to Common | 239.53 | 349.68 | 493.03 | 291.46 | 207.05 | 44.57 | Upgrade |
Net Income Growth | -40.02% | -29.07% | 69.16% | 40.77% | 364.49% | -63.70% | Upgrade |
Shares Outstanding (Basic) | 493 | 479 | 470 | 497 | 485 | 478 | Upgrade |
Shares Outstanding (Diluted) | 494 | 486 | 483 | 514 | 501 | 478 | Upgrade |
Shares Change (YoY) | 3.73% | 0.48% | -6.02% | 2.67% | 4.86% | 16.72% | Upgrade |
EPS (Basic) | 0.49 | 0.73 | 1.05 | 0.59 | 0.43 | 0.09 | Upgrade |
EPS (Diluted) | 0.48 | 0.72 | 1.02 | 0.57 | 0.41 | 0.09 | Upgrade |
EPS Growth | -42.18% | -29.41% | 79.99% | 37.12% | 342.98% | -68.90% | Upgrade |
Free Cash Flow | -63.02 | -18.65 | 110.37 | -14.23 | -184.88 | 167.63 | Upgrade |
Free Cash Flow Per Share | -0.13 | -0.04 | 0.23 | -0.03 | -0.37 | 0.35 | Upgrade |
Dividend Per Share | 0.249 | 0.249 | 0.667 | 0.333 | 0.333 | 0.013 | Upgrade |
Dividend Growth | -62.61% | -62.61% | 100.03% | - | 2406.01% | - | Upgrade |
Gross Margin | 40.49% | 46.69% | 56.48% | 46.48% | 39.93% | 43.96% | Upgrade |
Operating Margin | 19.78% | 26.94% | 36.08% | 25.67% | 11.08% | 13.31% | Upgrade |
Profit Margin | 16.55% | 21.77% | 31.14% | 19.62% | 16.97% | 4.55% | Upgrade |
Free Cash Flow Margin | -4.36% | -1.16% | 6.97% | -0.96% | -15.15% | 17.13% | Upgrade |
EBITDA | 394.9 | 526.73 | 645.57 | 443.36 | 207.05 | 182.71 | Upgrade |
EBITDA Margin | 27.29% | 32.79% | 40.77% | 29.84% | 16.97% | 18.67% | Upgrade |
D&A For EBITDA | 108.76 | 93.96 | 74.22 | 61.94 | 71.88 | 52.46 | Upgrade |
EBIT | 286.14 | 432.78 | 571.35 | 381.42 | 135.17 | 130.25 | Upgrade |
EBIT Margin | 19.78% | 26.94% | 36.08% | 25.67% | 11.08% | 13.31% | Upgrade |
Effective Tax Rate | 18.93% | 14.02% | 17.01% | 27.55% | 32.38% | 51.30% | Upgrade |
Revenue as Reported | 1,447 | 1,606 | 1,583 | 1,486 | 1,220 | 978.53 | Upgrade |
Advertising Expenses | - | 1.09 | 0.61 | 0.58 | 3.81 | 10.79 | Upgrade |
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.